ANIP ANI PHARMACEUTICALS INC Insider Trading

Director Walsh Patrick D sells 13,973 shares (28% of holdings) for $1.13M as stock trades below 52-week highs

Patrick Walsh, a director at ANI Pharmaceuticals, sold nearly fourteen thousand shares across two transactions in May, representing roughly a quarter of his direct shareholding and reducing his position from approximately 52,400 to 38,400 shares. The sales occurred at prices slightly below the current trading level, while the stock remains notably below its 52-week high—a period in which ANI has delivered strong fundamentals, including profitable operations, double-digit annual revenue growth, and a stable valuation multiple. This is Walsh's first open-market sales activity at ANI over the filing window, following his earlier acquisition of shares through stock-based compensation. The timing and magnitude of the disposition—liquidating a meaningful stake over consecutive trading days while the company demonstrates solid financial health—merit attention to whether this reflects portfolio rebalancing or a shift in Walsh's confidence in the company's near-term prospects.

ANIP President & CEO Lalwani sells 55,000 shares worth $4.3M; sixth open-market sale in 36 months despite profitable fundamentals.

Nikhil Lalwani, the company's President and CEO, sold a meaningful block of shares representing nearly 14% of his holdings. This is his sixth open-market sale at ANIP within the past three years, continuing a pattern of liquidation activity with no offsetting open-market purchases over the same period. The sale occurred while ANIP is profitable and growing revenue sharply, yet the stock is currently trading well below its 52-week high. His prior sales at this ticker show mixed timing—three of four prior sales with measurable outcomes were well-timed exits (the stock fell afterward), though one sale preceded gains. The insider's track record does not suggest conviction in near-term upside; rather, it shows a consistent pattern of trimming positions regardless of price action or fundamental strength.